Literature DB >> 22984283

Restoration of dopamine release deficits during object recognition memory acquisition attenuates cognitive impairment in a triple transgenic mice model of Alzheimer's disease.

Kioko Guzmán-Ramos1, Perla Moreno-Castilla, Monica Castro-Cruz, James L McGaugh, Hilda Martínez-Coria, Frank M LaFerla, Federico Bermúdez-Rattoni.   

Abstract

Previous findings indicate that the acquisition and consolidation of recognition memory involves dopaminergic activity. Although dopamine deregulation has been observed in Alzheimer's disease (AD) patients, the dysfunction of this neurotransmitter has not been investigated in animal models of AD. The aim of this study was to assess, by in vivo microdialysis, cortical and hippocampal dopamine, norepinephrine, and glutamate release during the acquisition of object recognition memory (ORM) in 5- and 10-mo-old triple-transgenic Alzheimer's disease mice (3xTg-AD) and to relate the extracellular changes to 24-h memory performance. Five- and 10-mo-old wild-type mice and 5-mo-old 3xTg-AD showed significant cortical but not hippocampal dopamine increase during object exploration. On a 24-h ORM test, these three groups displayed significant ORM. In contrast, 10-mo-old 3xTg-AD mice showed impaired dopamine release in the insular cortex during ORM acquisition, as well as significant impairment in ORM. In addition, cortical administration of a dopamine reuptake blocker produced an increase of dopamine levels in the 10-mo-old 3xTg-AD mice and attenuated the memory impairment. These data suggest that activation of the dopaminergic system in the insular cortex is involved in object recognition memory, and that dysfunction of this system contributes to the age-related decline in cognitive functioning of the 3xTg-AD mice.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22984283     DOI: 10.1101/lm.026070.112

Source DB:  PubMed          Journal:  Learn Mem        ISSN: 1072-0502            Impact factor:   2.460


  25 in total

Review 1.  Inhibiting BACE1 to reverse synaptic dysfunctions in Alzheimer's disease.

Authors:  Riqiang Yan; Qingyuan Fan; John Zhou; Robert Vassar
Journal:  Neurosci Biobehav Rev       Date:  2016-04-01       Impact factor: 8.989

2.  Dopamine receptor activity participates in hippocampal synaptic plasticity associated with novel object recognition.

Authors:  Kechun Yang; John I Broussard; Amber T Levine; Daniel Jenson; Benjamin R Arenkiel; John A Dani
Journal:  Eur J Neurosci       Date:  2016-10-01       Impact factor: 3.386

3.  Comparison of Efficacy of Preventive and Therapeutic Vaccines Targeting the N Terminus of β-Amyloid in an Animal Model of Alzheimer's Disease.

Authors:  Irina Petrushina; Hayk Davtyan; Armine Hovakimyan; Arpine Davtyan; Giselle F Passos; David H Cribbs; Anahit Ghochikyan; Michael G Agadjanyan
Journal:  Mol Ther       Date:  2017-01-04       Impact factor: 11.454

4.  Zinc supplementation ameliorates sorafenib-induced cognitive impairment through ROS/JNK signaling pathway.

Authors:  Can-Can Zhou; Yu-Qiong He; Yu-Shuang Qiu; Chen-Xu Ni; Fu-Ming Shen; Dong-Jie Li
Journal:  Biol Trace Elem Res       Date:  2022-02-07       Impact factor: 3.738

5.  Behavioural tagging: Effect of novelty exploration on plasticity related molecular signatures.

Authors:  Mehar Naseem; Shruti Vishnoi; Medha Kaushik; Suhel Parvez
Journal:  Exp Brain Res       Date:  2021-06-07       Impact factor: 1.972

6.  Risk neurogenes for long-term spaceflight: dopamine and serotonin brain system.

Authors:  N K Popova; A V Kulikov; E M Kondaurova; A S Tsybko; E A Kulikova; I B Krasnov; B S Shenkman; E Yu Bazhenova; N A Sinyakova; V S Naumenko
Journal:  Mol Neurobiol       Date:  2014-08-02       Impact factor: 5.590

Review 7.  Monoaminergic neuropathology in Alzheimer's disease.

Authors:  Goran Šimić; Mirjana Babić Leko; Selina Wray; Charles R Harrington; Ivana Delalle; Nataša Jovanov-Milošević; Danira Bažadona; Luc Buée; Rohan de Silva; Giuseppe Di Giovanni; Claude M Wischik; Patrick R Hof
Journal:  Prog Neurobiol       Date:  2016-04-12       Impact factor: 11.685

8.  Depressive-like behavior is paired to monoaminergic alteration in a murine model of Alzheimer's disease.

Authors:  Adele Romano; Lorenzo Pace; Bianca Tempesta; Angelo Michele Lavecchia; Teresa Macheda; Gaurav Bedse; Antonio Petrella; Carlo Cifani; Gaetano Serviddio; Gianluigi Vendemiale; Silvana Gaetani; Tommaso Cassano
Journal:  Int J Neuropsychopharmacol       Date:  2014-10-31       Impact factor: 5.176

9.  A shortened Barnes maze protocol reveals memory deficits at 4-months of age in the triple-transgenic mouse model of Alzheimer's disease.

Authors:  Aida Attar; Tingyu Liu; Wai-Ting Coco Chan; Jane Hayes; Mona Nejad; Kaichyuan Lei; Gal Bitan
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

Review 10.  "Is dopamine involved in Alzheimer's disease?".

Authors:  Alessandro Martorana; Giacomo Koch
Journal:  Front Aging Neurosci       Date:  2014-09-25       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.